美国上市药品（最近批准）
按批准日期最近更新
| 药品名称 | 商品名 | 申请号 | 产品编号 | 剂型 | 规格 | 企业 | 市场状态 | 批准日期 | 上市日期 |
|---|---|---|---|---|---|---|---|---|---|
| RUSFERTIDE ACETATE | MIMRYLO | NDA220605 | — | — | — | TAKEDA PHARMACEUTICALS U.S.A., INC. | — | 2026-08-28 | 2026-08-28 |
| CALCIUM GLUCONATE | CALCIUM GLUCONATE IN SODIUM CHLORIDE | ANDA219037 | — | — | — | MILLA PHARMS | — | 2026-08-28 | 2026-08-28 |
| RUSFERTIDE ACETATE | MIMRYLO | NDA220605 | 001 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | — | TAKEDA PHARMACEUTICALS U.S.A., INC. | Prescription | 2026-08-28 | 2026-08-28 |
| CALCIUM GLUCONATE | CALCIUM GLUCONATE IN SODIUM CHLORIDE | ANDA219037 | 001 | SOLUTION;INTRAVENOUS | 1GM/50ML (20MG/ML) | MILLA PHARMS | Prescription | 2026-08-28 | 2026-08-28 |
| CALCIUM GLUCONATE | CALCIUM GLUCONATE IN SODIUM CHLORIDE | ANDA219037 | 002 | SOLUTION;INTRAVENOUS | 2GM/100ML (20MG/ML) | MILLA PHARMS | Prescription | 2026-08-28 | 2026-08-28 |
| HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE | ANDA220938 | 001 | SOLUTION/DROPS;OTIC | 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML | ORBICULAR PHARM TECH | Prescription | 2026-08-27 | 2026-08-27 |
| FINERENONE | FINERENONE | ANDA220684 | 001 | TABLET;FILM COATED | 10MG | APOTEX INC | None (Tentative Approval) | 2026-08-27 | 2026-08-27 |
| FINERENONE | FINERENONE | ANDA220684 | 002 | TABLET;FILM COATED | 20MG | APOTEX INC | None (Tentative Approval) | 2026-08-27 | 2026-08-27 |
| FINERENONE | FINERENONE | ANDA220684 | 003 | TABLET;FILM COATED | 40MG | APOTEX INC | None (Tentative Approval) | 2026-08-27 | 2026-08-27 |
| RIOCIGUAT | RIOCIGUAT | ANDA219225 | 001 | TABLET; FILM COATED | 2.5MG | SANDOZ INC | None (Tentative Approval) | 2026-08-27 | 2026-08-27 |